-
A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared with Placebo in Adult Participants with Obesity or Overweight and Type 2 Diabetes
You are eligible if you are >18 years old and:
- are overweight (BMI>27kg/m2)
- have type 2 diabetes
- have a history of at least one dietary effort to lose body weight
A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants with Severe Obesity and Established Cardiovascular Disease
You are eligible if you are >18 years old and:
- are overweight (BMI>35kg/m2)
- have established cardiovascular disease and can answer yes to one of the following:
- prior myocardial infarction
- prior stroke
- peripheral arterial vascularization
- amputation due to vascular disease
- symptomatic vascular disease.
- have a history of at least one dietary effort to lose body weight
The Metformin Aneurysm Trial (MAT)
An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial to determine the effect of metformin on abdominal aortic aneurysm (AAA) associated events, including AAA repair and AAA mortality (due to aneurysm rupture).
You may be eligible if you:
- have an abdominal aortic aneurysm
- are aged between 18 – 79 years old
- are not taking metformin
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults with Obesity
You are eligible if you:
- are overweight (BMI>27kg/m2)
- do not have diabetes
- have established cardiovascular disease (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) OR can answer yes to two of the following:
- are a current smoker
- have high cholesterol
- have high blood pressure
- have kidney disease
- have prediabetes
- Home
- About us
- Publications
- Annual Highlights
- Annual Reports
- Aboriginal Health Cultural Safety Plan
- Aboriginal Workforce Plan 2023-2026
- Cancer Services Plan 2015-20
- Connect with Respect
- Eastern Health 2022
- Eastern Insight
- Gender Equality Action Plan
- Mental Health Royal Commission Submissions
- Quality Accounts
- Reconciliation Action Plan
- Research Reports
- Strategic Plan 2023-2025
- Turning Point Review
- Organisational Structure
- Consumer and Community Engagement
- Eastern Health Foundation
- Volunteers
- Policies and Guidelines
- Access to Patient Records
- Publications
- Services
- A–Z Service Directory
- Aboriginal Health
- Acute Specialist Clinics (Outpatients)
- Patient Revenue Services
- Telehealth
- Emergency Department
- Eastern Centre Against Sexual Assault
- Allied Health Services
- Maternity Services
- Mental Health and Wellbeing Service
- Our Response to the Royal Commission into Victoria’s Mental Health System
- Mental Health Wellbeing and Recovery
- Lived Experience Workforce - LEW
- Families where a Parent has a Mental Illness (FaPMI)
- Aboriginal and Torres Strait Islander Social and Emotional Wellbeing
- Child Youth Mental Health and Wellbeing Service
- Adult Mental Health
- Dual Diagnosis
- Older Adult Mental Health and Wellbeing Service
- NDIS
- Consultation-Liaison (CL) Psychiatry
- Eastern Mental Health Service Coordination Alliance
- Spectrum
- Language Services
- Imaging Services
- Pathology
- Alcohol and Drug Treatment (Turning Point)
- Locations
- Research & Ethics
- Latest News
- Guidance
- Research Programs
- Education and Training
- Research Data Services
- Library Services
- Funding Opportunities
- Research Enquiries
- Health Professionals
- Latest News
- Careers
- Contact us
Get Connected